Solventum (SOLV) Capital Expenditures (2023 - 2025)

Solventum (SOLV) has disclosed Capital Expenditures for 3 consecutive years, with $63.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 50.39% year-over-year to $63.0 million, compared with a TTM value of $379.0 million through Dec 2025, changed 0.26%, and an annual FY2025 reading of $379.0 million, changed 0.26% over the prior year.
  • Capital Expenditures was $63.0 million for Q4 2025 at Solventum, down from $97.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $127.0 million in Q4 2024 and bottomed at $58.0 million in Q2 2024.
  • Average Capital Expenditures over 3 years is $87.4 million, with a median of $90.5 million recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 89.66% in 2025, while the deepest fall reached 50.39% in 2025.
  • Year by year, Capital Expenditures stood at $88.0 million in 2023, then surged by 44.32% to $127.0 million in 2024, then tumbled by 50.39% to $63.0 million in 2025.
  • Business Quant data shows Capital Expenditures for SOLV at $63.0 million in Q4 2025, $97.0 million in Q3 2025, and $110.0 million in Q2 2025.